CareDx, Inc. (CDNA)

Name: CareDx, Inc. (CDNA) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001217234 · Nasdaq · Services-Medical Laboratories

Sector Services
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, CareDx, Inc. reported revenue of $379.81M. Revenue grew 13.8% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $458.09M.

Key ratios (year ended 2025-12-31)

-8.1%

Operating margin

-5.6%

Net margin

-7.0%

Return on year-end equity

13.8%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-05

Headquarters locality: Brisbane · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2017-09-30
Revenue	$458.09M	$379.81M	$333.79M	$280.32M	$321.79M	$296.40M	$192.19M	$127.07M	$76.57M	$48.32M	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$45.45M	$32.99M	$21.37M	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$81.61M	$43.58M	$26.95M	n/a
R&D Expense	$79.87M	$71.43M	$72.51M	$82.42M	$90.39M	$76.53M	$48.94M	$30.71M	$14.51M	$12.39M	n/a
Operating Income	$108.14M	-$30.78M	$40.77M	-$203.36M	-$77.23M	-$29.73M	-$22.53M	-$24.53M	-$15.58M	-$20.29M	n/a
Depreciation & Amortization	$14.41M	$15.02M	$14.19M	$14.39M	$11.60M	$8.80M	$7.01M	$5.52M	$4.21M	$3.73M	n/a
EBITDA	$122.54M	-$15.76M	$54.96M	-$188.98M	-$65.64M	-$20.93M	-$15.52M	-$19.01M	-$11.36M	-$16.57M	n/a
Net Income	$111.01M	-$21.35M	$52.55M	-$190.28M	-$76.61M	-$30.66M	-$18.71M	-$21.97M	-$46.76M	-$55.47M	n/a
EPS (Diluted)	n/a	-$0.40	$0.93	-$3.54	-$1.44	-$0.59	-$0.40	-$0.52	-$1.31	-$2.38	n/a
Total Assets	$532.99M	$413.23M	$491.05M	$466.83M	$542.99M	$566.62M	$368.51M	$151.74M	$130.70M	$83.56M	$75.09M
Total Liabilities	$107.39M	$110.13M	$112.62M	$205.50M	$112.08M	$100.75M	$90.83M	$52.74M	$34.77M	$89.52M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$34.06M	n/a
Shareholders' Equity	$425.60M	$303.10M	$378.43M	$261.33M	$430.91M	$465.88M	$277.68M	$99.00M	$95.93M	-$6.13M	n/a
Cash & Equivalents	$373.64M	$65.43M	$114.69M	$82.20M	$89.92M	$348.49M	$134.67M	$38.22M	$64.62M	$16.89M	n/a
Operating Cash Flow	$93.66M	$42.03M	$38.05M	-$18.39M	-$25.24M	-$19.29M	$33.43M	-$2.77M	-$4.01M	-$14.31M	n/a
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$2.04M	$186.0K	n/a
Free Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-$6.04M	-$14.49M	n/a
Share Repurchases	$50.00M	$87.77M	$522.0K	$27.54M	$642.0K	$0	$0	n/a	n/a	n/a	n/a
Shares Outstanding	51.48M	50.92M	54.77M	51.50M	53.53M	52.92M	49.44M	42.50M	41.38M	28.83M	n/a
Weighted Average Diluted Shares	n/a	53.29M	56.62M	53.76M	53.32M	52.24M	46.48M	42.15M	35.64M	23.33M	n/a
EPS (Basic)	n/a	-$0.40	$1.00	-$3.54	-$1.44	-$0.59	-$0.40	-$0.52	-$1.31	-$2.38	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView